LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | CP724714 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 10853 | 11155 | 0.9729 | 0.9681 |
MCF 10A | CP466722 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 11006 | 11155 | 0.9866 | 0.9843 |
MCF 10A | Crizotinib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 9010 | 11155 | 0.8077 | 0.7733 |
MCF 10A | Momelotinib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 7845 | 11155 | 0.7033 | 0.6502 |
MCF 10A | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 1852 | 11155 | 0.1661 | 0.0167 |
MCF 10A | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 1694 | 1327 | 11155 | 0.1190 | -0.0387 |
MCF 10A | Dovitinib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 2858 | 11155 | 0.2562 | 0.1230 |
MCF 10A | Enzastaurin | 3.33 | uM | LJP5 | 72 | hr | 1694 | 11663 | 11155 | 1.0455 | 1.0537 |
MCF 10A | Erlotinib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 2713 | 11155 | 0.2432 | 0.1077 |
MCF 10A | Foretinib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 2325 | 11155 | 0.2084 | 0.0667 |
MCF 10A | R406 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 10161 | 11155 | 0.9109 | 0.8949 |
MCF 10A | Pictilisib | 3.33 | uM | LJP6 | 72 | hr | 1694 | 3606 | 11155 | 0.3232 | 0.2021 |
MCF 10A | Gefitinib | 3.33 | uM | LJP6 | 72 | hr | 1694 | 2475 | 11155 | 0.2219 | 0.0826 |
MCF 10A | Geldanamycin | 3.33 | uM | LJP5 | 72 | hr | 1694 | 1107 | 11155 | 0.0993 | -0.0620 |
MCF 10A | Geldanamycin | 3.33 | uM | LJP6 | 72 | hr | 1694 | 1042 | 11155 | 0.0935 | -0.0689 |
MCF 10A | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 1343 | 11155 | 0.1204 | -0.0371 |
MCF 10A | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 2032 | 11155 | 0.1822 | 0.0357 |
MCF 10A | GSK1904529A | 3.33 | uM | LJP6 | 72 | hr | 1694 | 6293 | 11155 | 0.5641 | 0.4861 |
MCF 10A | Omipalisib | 3.33 | uM | LJP6 | 72 | hr | 1694 | 1499 | 11155 | 0.1344 | -0.0206 |
MCF 10A | GSK 690693 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 9870 | 11155 | 0.8848 | 0.8642 |
MCF 10A | GW843682X | 3.33 | uM | LJP6 | 72 | hr | 1694 | 970 | 11155 | 0.0870 | -0.0765 |
MCF 10A | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 5021 | 11155 | 0.4501 | 0.3517 |
MCF 10A | HG-5-88-01 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 6402 | 11155 | 0.5739 | 0.4976 |
MCF 10A | Imatinib | 3.33 | uM | LJP6 | 72 | hr | 1694 | 11454 | 11155 | 1.0267 | 1.0315 |
MCF 10A | JNK-9L | 3.33 | uM | LJP6 | 72 | hr | 1694 | 575 | 11155 | 0.0515 | -0.1183 |